应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09996 沛嘉医疗-B
交易中 11-04 14:43:34
3.715
+0.090
+2.48%
最高
3.785
最低
3.580
成交量
157.30万
今开
3.625
昨收
3.625
日振幅
5.66%
总市值
25.15亿
流通市值
25.15亿
总股本
6.77亿
成交额
578.46万
换手率
0.23%
流通股本
6.77亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中信建投:Q3多家公司超预期 看好2027年医疗器械与服务业绩改善趋势
智通财经 · 07:45
中信建投:Q3多家公司超预期 看好2027年医疗器械与服务业绩改善趋势
股市必读:乐心股份新发布《关于完成医疗器械注册证变更的公告》
证券之星 · 02:18
股市必读:乐心股份新发布《关于完成医疗器械注册证变更的公告》
爱朋医疗:公司已获得两张多模态ADHD行为治疗系统相关组件的第二类医疗器械注册证
证券之星 · 11-03 11:37
爱朋医疗:公司已获得两张多模态ADHD行为治疗系统相关组件的第二类医疗器械注册证
【券商聚焦】中信证券:国内医药板块业绩持续修复
金吾财讯 · 11-02 08:40
【券商聚焦】中信证券:国内医药板块业绩持续修复
股市必读:达安基因新发布《关于下属子公司取得医疗器械注册证的提示性公告》
证券之星 · 11-02 06:00
股市必读:达安基因新发布《关于下属子公司取得医疗器械注册证的提示性公告》
脑动极光(06681)大涨19% 近期获抑郁症领域首张认知评估医疗器械注册证
金吾财讯 · 10-29
脑动极光(06681)大涨19% 近期获抑郁症领域首张认知评估医疗器械注册证
探馆第94届CMEF及系列展:透视北京医药健康创新链落地刻度,从展台“首款”到病床“可及”还有几道关
华夏时报网 · 10-28
探馆第94届CMEF及系列展:透视北京医药健康创新链落地刻度,从展台“首款”到病床“可及”还有几道关
维力医疗最新公告:获得一次性使用亲水涂层间歇性导尿管医疗器械注册证
证券之星 · 10-28
维力医疗最新公告:获得一次性使用亲水涂层间歇性导尿管医疗器械注册证
图片新闻-中国质量新闻网
中国质量新闻网 · 10-28
图片新闻-中国质量新闻网
港股异动 | 脑动极光-B(06681)高开逾3% 获北京市药监局下发抑郁症领域首张认知功能评估医疗器械注册证
智通财经 · 10-28
港股异动 | 脑动极光-B(06681)高开逾3% 获北京市药监局下发抑郁症领域首张认知功能评估医疗器械注册证
脑动极光-B(06681.HK):用于抑郁症患者的认知功能评估产品获北京市药品监督管理局第二类医疗器械注册证
智通财经 · 10-28
脑动极光-B(06681.HK):用于抑郁症患者的认知功能评估产品获北京市药品监督管理局第二类医疗器械注册证
深圳市市场监督管理局召开脑机接口医疗器械专题学习研讨会
格隆汇 · 10-26
深圳市市场监督管理局召开脑机接口医疗器械专题学习研讨会
主力热捧医疗,医疗ETF华宝(512170)放量上穿年线!医疗器械挑大梁,拐点到了?2000亿巨头9连阳
新浪基金 · 10-26
主力热捧医疗,医疗ETF华宝(512170)放量上穿年线!医疗器械挑大梁,拐点到了?2000亿巨头9连阳
【投融资动态】启宇原生物A轮融资,投资方为兴湘集团、长财私募基金等
证券之星 · 10-26
【投融资动态】启宇原生物A轮融资,投资方为兴湘集团、长财私募基金等
2000亿医疗器械龙头,9连阳
同花顺 · 10-26
2000亿医疗器械龙头,9连阳
股市必读:康泰医学新发布《关于公司医疗器械注册证变更的公告》
证券之星 · 10-26
股市必读:康泰医学新发布《关于公司医疗器械注册证变更的公告》
股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司关于自愿披露全资子公司获得医疗器械注册证的公告》
证券之星 · 10-26
股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司关于自愿披露全资子公司获得医疗器械注册证的公告》
浩欧博(688656)披露全资子公司获得医疗器械注册证,10月22日股价下跌6.11%
证券之星 · 10-22
浩欧博(688656)披露全资子公司获得医疗器械注册证,10月22日股价下跌6.11%
股市必读:新华医疗新发布《新华医疗关于公司产品获得三类和二类医疗器械注册证的公告》
证券之星 · 10-22
股市必读:新华医疗新发布《新华医疗关于公司产品获得三类和二类医疗器械注册证的公告》
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
证券之星 · 10-22
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
加载更多
公司概况
公司名称:
沛嘉医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部,经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。
发行价格:
--
{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":3.715,"timestamp":1793774590184,"preClose":3.625,"halted":0,"volume":1573000,"delay":0,"changeRate":0.024827586206896513,"floatShares":677000000,"shares":677000000,"eps":-0.305587,"marketStatus":"交易中","change":0.09,"latestTime":"11-04 14:43:34","open":3.625,"high":3.785,"low":3.58,"amount":5784565,"amplitude":0.056552,"askPrice":3.725,"askSize":9000,"bidPrice":3.715,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.243897,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793779800000},"marketStatusCode":2,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":3.625,"openAndCloseTimeList":[[1793755800000,1793764800000],[1793768400000,1793779200000]],"volumeRatio":3.384666,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2680709322","title":"中信建投:Q3多家公司超预期 看好2027年医疗器械与服务业绩改善趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2680709322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680709322?lang=zh_cn&edition=full","pubTime":"2026-11-04 07:45","pubTimestamp":1793749504,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中信建投发布研报称,医疗器械板块Q3收入延续增长趋势,季度利润连续两个季度实现正增长,多家龙头公司业绩超预期,且有望于27年业绩加速增长。医疗服务Q3收入延续正增长,盈利能力有所修复。医疗器械:Q3多家公司业绩超预期、27年有望业绩改善,板块效应将逐步体现。2026Q3板块营收、归母净利润、扣非归母净利润同比增速分别为5.02%、11.47%、12.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HART","BK0276","IEIH","MEDX","09996","RSPH","BK1583","PTH","LNGR","601066","LGHT","BK1574","BK1100","AGNG","159883","MDEV","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680779830","title":"股市必读:乐心股份新发布《关于完成医疗器械注册证变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680779830","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680779830?lang=zh_cn&edition=full","pubTime":"2026-11-04 02:18","pubTimestamp":1793729911,"startTime":"0","endTime":"0","summary":"公司公告汇总关于完成医疗器械注册证变更的公告广东乐心医疗电子股份有限公司近日收到南德认证检测(中国)有限公司回复,电子血压计医疗器械CE符合性证书变更已通过审批;新增BUA6400CEME、BUA6400WE两个型号,注册分类为IIa类;产品由主机和袖带组成,适用于臂围22cm–45cm的成年人测量血压和脉率,包括患有糖尿病、妊娠或子痫前期人群;测量数据可通过LCD显示,供诊断参考。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400003980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0251","BK1583","BK0114","09996","BK1100","BK0109","BK1574","300562"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680141715","title":"爱朋医疗:公司已获得两张多模态ADHD行为治疗系统相关组件的第二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2680141715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680141715?lang=zh_cn&edition=full","pubTime":"2026-11-03 11:37","pubTimestamp":1793677038,"startTime":"0","endTime":"0","summary":"证券之星消息,爱朋医疗11月02日在投资者关系平台上答复投资者关心的问题。请问贵公司的多动症ADHD脑机接口器械获批了吗?谢谢爱朋医疗回复:您好,公司已获得两张多模态ADHD行为治疗系统相关组件的第二类医疗器械注册证,产品正在有序开展销售工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300018593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","BK0251","09996","300753","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680717785","title":"【券商聚焦】中信证券:国内医药板块业绩持续修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680717785","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680717785?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:40","pubTimestamp":1793580014,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券发布2027年医疗健康行业投资策略,“十五五”开局之年,医药行业首次列为国家新兴支柱产业,紧随其后的价格机制优化改革 、支持创新药械高定价、以及推动商业医疗保险发展等行业增量改革政策趋势,叠加国内医药行业在创新领域集中兑现等产业内外催化因素驱动下,该机构看到2026H1国内医药板块业绩持续修复,尤其是创新药、创新器械等新兴产业板块。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","159938","06990","LU0039217434.USD","LU0455707207.USD","LU0348825331.USD","02162","06996","LU0979878070.USD","IE00B031HY20.USD","BK0028","02268","01530","03692","01177","HK0000320264.USD","LU1969619763.USD","01952","09939","01276","01548","02269","LU1226287529.USD","02596","06821","01093","09926","LU0823426480.USD","01951","00013","09996","03759","LU2488822045.USD","LU0828237510.HKD","06030","LU1064131003.USD","KCE","06078","LU0607220059.USD","KURE","LU0708995153.HKD","01801","LU1794554557.SGD","09966","02096","02273","600030","LU0708995583.HKD","LU0348766576.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680888277","title":"股市必读:达安基因新发布《关于下属子公司取得医疗器械注册证的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680888277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680888277?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:00","pubTimestamp":1793570447,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,达安基因报收于5.18元,下跌1.71%,换手率1.33%,成交量18.65万手,成交额9784.27万元。公司公告汇总关于下属子公司取得医疗器械注册证的提示性公告广州达安基因股份有限公司下属全资子公司达安基因(中山)有限公司取得国家药品监督管理局颁发的医疗器械注册证,产品名称为基孔肯雅病毒抗原检测试剂盒,注册证编号国械注准20263402223,有效期至2031年10月29日。阴性结果不能排除感染,不得单独作为治疗依据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","159883","BK0042","BK0168","BK0239","BK1583","09996","BK0159","BK0122","BK1100","BK0188","BK1574","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679425200","title":"脑动极光(06681)大涨19% 近期获抑郁症领域首张认知评估医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2679425200","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679425200?lang=zh_cn&edition=full","pubTime":"2026-10-29 13:52","pubTimestamp":1793253178,"startTime":"0","endTime":"0","summary":"金吾财讯 | 脑动极光-B(06681)股价延续近期升势,最新报2.17港元,涨19.23%,成交额8.89亿港元。该股近8个交易日累计涨幅超248%。公司公布,公司收到北京市药品监督管理局颁发的针对抑郁症患者认知功能评估软件第二类医疗器械注册证。该产品临床试验于2024年9月启动,并于2025年8月完成。集团表示,该产品为公司首个获北京市药品监督管理局批准注册的医疗器械产品,亦是抑郁症领域首个取得注册证的认知功能评估医疗器械产品,标志公司在精神疾病认知评估领域取得注册突破,并具备先发优势,同时进一步完善认知障碍数字医疗产品布局。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994783","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06681","AGNG","159883","BK1574","MEDX","RSPH","GDOC","LNGR","BK1189","HART","MDEV","IEIH","PTH","BK1100","09996","LGHT","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678498647","title":"探馆第94届CMEF及系列展:透视北京医药健康创新链落地刻度,从展台“首款”到病床“可及”还有几道关","url":"https://stock-news.laohu8.com/highlight/detail?id=2678498647","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678498647?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:08","pubTimestamp":1793189318,"startTime":"0","endTime":"0","summary":"探馆第94届CMEF及系列展:透视北京医药健康创新链落地刻度,从展台“首款”到病床“可及”还有几道关","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610283912401060.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610283912401060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GDOC","09996","PTH","AGIX","PYZ","IE00B7SZL793.SGD","IE00B66KJ199.SGD","IEIH","LU2065731478.USD","MDEV","QTOC","BK1574","HART","RSPH","CHAT","AIPO","IE0031619046.USD","MEDX","CRS","ARTY","BK1100","BK4187","LU0963586101.USD","BK4006","LGHT","BMED","XAR","IE00B19Z4B17.USD","AGNG","VTHR","LNGR","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678546444","title":"维力医疗最新公告:获得一次性使用亲水涂层间歇性导尿管医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2678546444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678546444?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:56","pubTimestamp":1793177792,"startTime":"0","endTime":"0","summary":"维力医疗(603309.SH)公告称,公司近日收到广东省药品监督管理局颁发的二类医疗器械注册证,产品为一次性使用亲水涂层间歇性导尿管,适用于将病人膀胱中的尿液经尿道向体外导出并导入到集尿容器中,间歇性导尿。此次获证有利于丰富公司产品种类,提升市场竞争力,对公司经营产生积极影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800037020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603309","159883","BK0251","BK1583","09996","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678456838","title":"图片新闻-中国质量新闻网","url":"https://stock-news.laohu8.com/highlight/detail?id=2678456838","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678456838?lang=zh_cn&edition=full","pubTime":"2026-10-28 15:39","pubTimestamp":1793173140,"startTime":"0","endTime":"0","summary":"转自:中国质量报近日,广西南宁市市场监管局开展医疗器械经营环节专项监督检查。执法人员重点核查医疗器械经营主体资质,及产品来源、进货记录、储存条件等,排查风险隐患,督促经营主体严格落实质量安全主体责任,规范经营行为。图为该局执法人员在一家医疗器械经营店进行检查。何正君 摄","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-10-28/doc-iniwukpx9501954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","IEIH","RSPH","BK1583","BK1574","BK1100","PTH","LGHT","GDOC","MDEV","HART","MEDX","AGNG","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678433558","title":"港股异动 | 脑动极光-B(06681)高开逾3% 获北京市药监局下发抑郁症领域首张认知功能评估医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2678433558","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678433558?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:29","pubTimestamp":1793150986,"startTime":"0","endTime":"0","summary":"公告称,该产品为本公司获得的北京局第一张医疗器械注册证,亦为抑郁症领域首张认知功能评估医疗器械注册证,标志着本公司在精神疾病认知评估领域取得注册突破,占据市场先发位置,并进一步完善本公司认知障碍数字医疗产品布局。董事会认为,上述注册成果有助于巩固本集团在认知障碍数字医疗领域的行业地位,符合本集团及股东整体利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RSPH","AGNG","VXUS","BK4588","159883","MEDX","BK4585","HART","KCAI","BK1583","BK1100","06681","GDOC","09996","BK1574","LGHT","BK1189","LNGR","PTH","MDEV","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678948411","title":"脑动极光-B(06681.HK):用于抑郁症患者的认知功能评估产品获北京市药品监督管理局第二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2678948411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678948411?lang=zh_cn&edition=full","pubTime":"2026-10-28 06:35","pubTimestamp":1793140521,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06681","BK1583","09996","BK1574","BK1100","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678989631","title":"深圳市市场监督管理局召开脑机接口医疗器械专题学习研讨会","url":"https://stock-news.laohu8.com/highlight/detail?id=2678989631","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678989631?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:02","pubTimestamp":1793016174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PTH","LNGR","RSPH","159883","AGNG","IBRN","BK1583","LGHT","MDEV","09996","MEDX","BK1100","HART","IEIH","BK1574","GDOC","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678816019","title":"主力热捧医疗,医疗ETF华宝(512170)放量上穿年线!医疗器械挑大梁,拐点到了?2000亿巨头9连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2678816019","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678816019?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:39","pubTimestamp":1793014740,"startTime":"0","endTime":"0","summary":"10月26日,A股弱势震荡,医疗强势突围,器械股一马当先,新产业领涨9.34%,大博医疗涨7.22%,三诺生物涨6.89%,2000亿市值巨头迈瑞医疗涨3.63%创6个月新高,斩获9连阳!中证医疗指数收涨1.71%收于日内高点,跟踪该指数的医疗ETF华宝一度突破年线,收盘成功收复20日线及60日线,场内交投活跃,成交显著放量。一键跟上医疗修复行情,投资工具关注:医疗ETF华宝:医药医疗类ETF旗舰,二季报规模256.24亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-26/doc-iniwqarp9279869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["512170","BK1583","PTH","RSPH","09996","BK1574","LGHT","MDEV","MEDX","HART","AGNG","159891","GDOC","LNGR","BK1100","159883","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678603141","title":"【投融资动态】启宇原生物A轮融资,投资方为兴湘集团、长财私募基金等","url":"https://stock-news.laohu8.com/highlight/detail?id=2678603141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678603141?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:28","pubTimestamp":1793014105,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于10月20日公布的信息整理,湖南启宇原生物科技有限公司A轮融资,融资额未披露,参与投资的机构包括兴湘集团,长财私募基金,三美投资,湖南高新创投。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600030418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1100","09996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678315664","title":"2000亿医疗器械龙头,9连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2678315664","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678315664?lang=zh_cn&edition=full","pubTime":"2026-10-26 12:25","pubTimestamp":1792988700,"startTime":"0","endTime":"0","summary":"10月26日上午A股收盘,上证指数下跌0.18%,深证成指下跌1.05%,创业板指下跌1.65%,科创综指下跌1.6%。全市场逾2900只个股下跌,成交额为10156亿元。高股息资产、大消费、医药等板块上午表 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261026/c681074722.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261026/c681074722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["HART","RSPH","AGNG","BK1583","GDOC","IEIH","LNGR","MDEV","MEDX","BK1574","159883","PTH","09996","LGHT","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678412132","title":"股市必读:康泰医学新发布《关于公司医疗器械注册证变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678412132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678412132?lang=zh_cn&edition=full","pubTime":"2026-10-26 08:25","pubTimestamp":1792974312,"startTime":"0","endTime":"0","summary":"公司公告汇总:公司获河北省药监局批准医用压缩式雾化器医疗器械变更注册,规格型号新增“NE-J02”,结构及组成、产品技术要求同步变更,批准日期为2026年9月17日。公司公告汇总关于公司医疗器械注册证变更的公告康泰医学系统(秦皇岛)股份有限公司近日收到河北省药品监督管理局颁发的《医疗器械变更注册文件》,产品名称为医用压缩式雾化器,注册证编号为冀械注准20232080181。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600002329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK0251","BK1583","BK1100","300869","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678213178","title":"股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司关于自愿披露全资子公司获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678213178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678213178?lang=zh_cn&edition=full","pubTime":"2026-10-26 06:50","pubTimestamp":1792968624,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏浩欧博生物医药股份有限公司关于自愿披露全资子公司获得医疗器械注册证的公告江苏浩欧博生物医药股份有限公司全资子公司湖南浩欧博生物医药有限公司近日获得湖南省药品监督管理局核发的1项医疗器械注册证,产品为抗桥粒芯糖蛋白1抗体检测试剂盒,注册证编号湘械注准20262400551,有效期至2031年10月20日,用于体外定性检测人血清样本中抗Dsg1抗体,临床上主要用于落叶型天疱疮的辅助诊断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","159883","BK1100","BK0239","09996","BK1583","161726","399441","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677617809","title":"浩欧博(688656)披露全资子公司获得医疗器械注册证,10月22日股价下跌6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677617809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677617809?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:31","pubTimestamp":1792679472,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,浩欧博报收于99.0元,较前一交易日下跌6.11%,最新总市值为62.88亿元。该股当日开盘105.44元,最高107.8元,最低99.0元,成交额达5283.61万元,换手率为0.82%。该注册证的取得有助于丰富公司化学发光平台检测菜单,提升市场综合竞争力,对公司及子公司的可持续发展具有积极影响。上述产品实际销售情况取决于市场拓展效果,目前未对公司当期及未来业绩构成影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200042882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","688656","BK0239","159883","BK1583","BK1100","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677060100","title":"股市必读:新华医疗新发布《新华医疗关于公司产品获得三类和二类医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677060100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677060100?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:56","pubTimestamp":1792612571,"startTime":"0","endTime":"0","summary":"公司公告汇总新华医疗关于公司产品获得三类和二类医疗器械注册证的公告山东新华医疗器械股份有限公司及子公司近日获得多项医疗器械注册证。子公司新华手术器械有限公司取得三类医疗器械注册证,产品为等离子手术设备,适用于内窥镜手术中关节部位软组织的切割、凝血和汽化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","09996","BK1100","BK1574","BK0188","600587","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677011716","title":"股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677011716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677011716?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:32","pubTimestamp":1792611130,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,三鑫医疗报收于9.26元,上涨0.0%,换手率1.33%,成交量4.86万手,成交额4531.66万元。当日关注点交易信息汇总:10月21日主力资金净流出88.71万元,占总成交额1.96%;游资资金净流出506.42万元,占总成交额11.17%。公司公告汇总:控股二级子公司江西钶维肽生物科技有限公司获颁漏血监测器《医疗器械注册证》,属江西省第二类创新医疗器械,有效期至2031年10月15日。该产品采用生物电流识别技术,已被认定为江西省第二类创新医疗器械。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","09996","BK1583","159883","300453","BK1574","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.1027},{"period":"1month","weight":-0.2094},{"period":"3month","weight":-0.1159},{"period":"6month","weight":-0.3938},{"period":"1year","weight":-0.3948},{"period":"ytd","weight":-0.3968}],"compareEarnings":[{"period":"1week","weight":0.021},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0922},{"period":"6month","weight":-0.1164},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.0821}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部,经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100991},{"month":4,"riseRate":0.8,"avgChangeRate":0.053778},{"month":5,"riseRate":0.6,"avgChangeRate":-0.096849},{"month":6,"riseRate":0.571429,"avgChangeRate":0.041819},{"month":7,"riseRate":0.571429,"avgChangeRate":0.044814},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.034075},{"month":9,"riseRate":0.285714,"avgChangeRate":0.002992},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.03551},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.028754},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}